BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 23, Issue 22
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (11188)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.
Item 
Count 
PDF997
WORD601
HTML6729
Figures (1-1)155
Tables (1-1)144
 Sum=8626
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1139
Download1423
 Sum=2562
Jun 14, 2017 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Halkjær SI, Boolsen AW, Günther S, Christensen AH, Petersen AM. Can fecal microbiota transplantation cure irritable bowel syndrome? World J Gastroenterol 2017; 23(22): 4112-4120 [PMID: 28652664 DOI: 10.3748/wjg.v23.i22.4112]
URL: https://www.wjgnet.com/1007-9327/full/v23/i22/4112.htm
Number Citing Articles
1
Seonhye Yu, Eunho Chun, Yeounjung Ji, Young Joo Lee, Mirim Jin. Effects of red ginseng on gut, microbiota, and brain in a mouse model of post-infectious irritable bowel syndrome. Journal of Ginseng Research 2021; 45(6): 706 doi: 10.1016/j.jgr.2021.03.008
2
Enrico Patrono, Jan Svoboda, Aleš Stuchlík. Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis. Behavioral and Brain Functions 2021; 17(1) doi: 10.1186/s12993-021-00180-2
3
Dorota Kujawa, Lukasz Laczmanski, Slawomir Budrewicz, Anna Pokryszko-Dragan, Maria Podbielska. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2274126
4
Mariana X. Byndloss, Sandy R. Pernitzsch, Andreas J. Bäumler. Healthy hosts rule within: ecological forces shaping the gut microbiota. Mucosal Immunology 2018; 11(5): 1299 doi: 10.1038/s41385-018-0010-y
5
Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Oksana Sulaieva, Tetyana Falalyeyeva, Nazarii Kobyliak. Fecal microbiota transplantation in patients with post-infectious irritable bowel syndrome: A randomized, clinical trial. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.994911
6
Sahil Khanna. Microbiota Replacement Therapies: Innovation in Gastrointestinal Care. Clinical Pharmacology & Therapeutics 2018; 103(1): 102 doi: 10.1002/cpt.923
7
Yuvaraj Balan, Archana Gaur, Varatharajan Sakthivadivel, Bhushan Kamble, Raja Sundaramurthy. Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?. Cureus 2021;  doi: 10.7759/cureus.19740
8
Mikołaj Świerczyński, Agata Szymaszkiewicz. A Comprehensive Overview of Irritable Bowel Syndrome. 2020; : 167 doi: 10.1016/B978-0-12-821324-7.00014-9
9
Sofie Ingdam Halkjær, Alice Højer Christensen, Bobby Zhao Sheng Lo, Patrick Denis Browne, Stig Günther, Lars Hestbjerg Hansen, Andreas Munk Petersen. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut 2018; 67(12): 2107 doi: 10.1136/gutjnl-2018-316434
10
Wen‐Hung Hsu, Jaw‐Yuan Wang, Chao‐Hung Kuo. Current applications of fecal microbiota transplantation in intestinal disorders. The Kaohsiung Journal of Medical Sciences 2019; 35(6): 327 doi: 10.1002/kjm2.12069
11
Legaki Evangelia, Eleni Anna Karanasou, Maria Gazouli. Gut Microbiome-Related Diseases and Therapies. The Microbiomes of Humans, Animals, Plants, and the Environment 2021; 1: 41 doi: 10.1007/978-3-030-59642-2_3
12
Thomas Borody. Gastrointestinal Diseases and their Associated Infections. 2019; : 249 doi: 10.1016/B978-0-323-54843-4.00018-0
13
Xinting Wang, Jihong Wu, Rui Huang, Shenglan Wang. Moxibustion improved the effect of fecal microbiota transplantation donor to dextran sulfate sodium‐induced colitis in mice. The Anatomical Record 2023; 306(12): 3144 doi: 10.1002/ar.25135
14
Craig Haifer, Colleen R Kelly, Sudarshan Paramsothy, David Andresen, Lito E Papanicolas, Genevieve L McKew, Thomas J Borody, Michael Kamm, Samuel P Costello, Jane M Andrews, Jakob Begun, Hiu Tat Chan, Susan Connor, Simon Ghaly, Paul DR Johnson, Daniel A Lemberg, Ramesh Paramsothy, Andrew Redmond, Harsha Sheorey, David van der Poorten, Rupert W Leong. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut 2020; 69(5): 801 doi: 10.1136/gutjnl-2019-320260
15
Kieran Rea, Siobhain M. O' Mahony, John F. Cryan. High and Mighty? Cannabinoids and the microbiome in pain. Neurobiology of Pain 2021; 9: 100061 doi: 10.1016/j.ynpai.2021.100061
16
Shunya Kurokawa, Taishiro Kishimoto, Shinta Mizuno, Tatsuhiro Masaoka, Makoto Naganuma, Kuo-ching Liang, Momoko Kitazawa, Moeko Nakashima, Chie Shindo, Wataru Suda, Masahira Hattori, Takanori Kanai, Masaru Mimura. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study. Journal of Affective Disorders 2018; 235: 506 doi: 10.1016/j.jad.2018.04.038
17
David C. Bulmer, Carolina Roza. The Oxford Handbook of the Neurobiology of Pain. 2018; : 470 doi: 10.1093/oxfordhb/9780190860509.013.12
18
Katherine J. P. Schwenger, Colin M. Bolzon, Carrie Li, Johane P. Allard. Non-alcoholic fatty liver disease and obesity: the role of the gut bacteria. European Journal of Nutrition 2019; 58(5): 1771 doi: 10.1007/s00394-018-1844-5
19
Lucinda A. Harris, Noemi Baffy. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgraduate Medicine 2017; 129(8): 872 doi: 10.1080/00325481.2017.1383819
20
Salvatore Fabbiano, Nicolas Suárez-Zamorano, Mirko Trajkovski. Host–Microbiota Mutualism in Metabolic Diseases. Frontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00267
21
Ajit Sood, Vandana Midha, Harmeet Kaur, Arshdeep Singh. Fecal Microbiota Transplantation in Intestinal Disorders: A Primer for Physicians . Journal of Gastrointestinal Infections 2020; 10(1): 16 doi: 10.5005/jp-journals-10068-3041
22
Leon Pawlik, Aleksandra Tarasiuk. A Comprehensive Overview of Irritable Bowel Syndrome. 2020; : 27 doi: 10.1016/B978-0-12-821324-7.00003-4
23
Tomohisa Takagi, Yuji Naito, Ryo Inoue, Saori Kashiwagi, Kazuhiko Uchiyama, Katsura Mizushima, Saeko Tsuchiya, Osamu Dohi, Naohisa Yoshida, Kazuhiro Kamada, Takeshi Ishikawa, Osamu Handa, Hideyuki Konishi, Kayo Okuda, Yoshimasa Tsujimoto, Hiromu Ohnogi, Yoshito Itoh. Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. Journal of Gastroenterology 2019; 54(1): 53 doi: 10.1007/s00535-018-1488-5
24
Max Schmulson, Mohammad Bashashati. Fecal microbiota transfer for bowel disorders: efficacy or hype?. Current Opinion in Pharmacology 2018; 43: 72 doi: 10.1016/j.coph.2018.08.012
25
Atsushi Nishida, Hirotsugu Imaeda, Osamu Inatomi, Shigeki Bamba, Mitsushige Sugimoto, Akira Andoh. The efficacy of fecal microbiota transplantation for patients with chronic pouchitis: A case series. Clinical Case Reports 2019; 7(4): 782 doi: 10.1002/ccr3.2096
26
J. Sarada, S. Anju, Y. Aparna, K. Anuradha. Microbiome in Human Health and Disease. 2021; : 217 doi: 10.1007/978-981-16-3156-6_11
27
E. L. Nikonov, V. A. Aksenov. Transplantation of fecal microbiota or probiotics?. Dokazatel'naya gastroenterologiya 2017; 6(3): 19 doi: 10.17116/dokgastro20176319-25
28
Amin Talebi Bezmin Abadi. Fecal microbiota transplantation against irritable bowel syndrome? Rigorous randomized clinical trials are required. World Journal of Gastrointestinal Pharmacology and Therapeutics 2017; 8(4): 208-209 doi: 10.4292/wjgpt.v8.i4.208
29
Jing Ma, Jianhui Li, Meirui Qian, Nan He, Ying Cao, Yaping Liu, Kaichun Wu, Shuixiang He. The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity. The FASEB Journal 2019; 33(12): 13560 doi: 10.1096/fj.201901489R
30
Pei Pei Chong, Voon Kin Chin, Chung Yeng Looi, Won Fen Wong, Priya Madhavan, Voon Chen Yong. The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy. Frontiers in Microbiology 2019; 10 doi: 10.3389/fmicb.2019.01136
31
Kieran Rea, Siobhain O’Mahony, Timothy G Dinan, John F Cryan. Pain Bugs: Gut Microbiota and Pain Disorders. Current Opinion in Physiology 2019; 11: 97 doi: 10.1016/j.cophys.2019.10.001
32
Sofie Ingdam Halkjær, Bobby Lo, Frederik Cold, Alice Højer Christensen, Savanne Holster, Julia König, Robert Jan Brummer, Olga C Aroniadis, Perttu Lahtinen, Tom Holvoet, Lise Lotte Gluud, Andreas Munk Petersen. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. World Journal of Gastroenterology 2023; 29(20): 3185-3202 doi: 10.3748/wjg.v29.i20.3185
33
Kanchana Myneedu, Abhizith Deoker, Max J Schmulson, Mohammad Bashashati. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta‐analysis. United European Gastroenterology Journal 2019; 7(8): 1033 doi: 10.1177/2050640619866990
34
Charles C. Herndon, Yen‐Po Wang, Ching‐Liang Lu. Targeting the gut microbiota for the treatment of irritable bowel syndrome. The Kaohsiung Journal of Medical Sciences 2020; 36(3): 160 doi: 10.1002/kjm2.12154
35
Dabo Xu, Vincent L. Chen, Calen A. Steiner, Jeffrey A. Berinstein, Shanti Eswaran, Akbar K. Waljee, Peter D.R. Higgins, Chung Owyang. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 2019; 114(7): 1043 doi: 10.14309/ajg.0000000000000198
36
Paolo Costa. Chronic Pelvic Pain and Pelvic Dysfunctions. Urodynamics, Neurourology and Pelvic Floor Dysfunctions 2021; : 9 doi: 10.1007/978-3-030-56387-5_2
37
Kai Zhan, Huan Zheng, Jianqing Li, Haomeng Wu, Shumin Qin, Lei Luo, Shaogang Huang, Loris Riccardo Lopetuso. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/3828249
38
Sofie I Halkjaer, Bobby Lo, Frederik Cold, Alice Hoejer H Christensen, Lise Lotte Gluud, Andreas M Petersen. Fecal microbiota transplantation for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013602
39
Magnus Simrén, Jan Tack. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nature Reviews Gastroenterology & Hepatology 2018; 15(10): 589 doi: 10.1038/s41575-018-0034-5
40
Karolina Skonieczna-Żydecka, Igor Loniewski, Anastasios Koulaouzidis, Wojciech Marlicz. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; : 251 doi: 10.1016/B978-0-12-815249-2.00026-9
41
R.E. Ooijevaar, E.M. Terveer, H.W. Verspaget, E.J. Kuijper, J.J. Keller. Clinical Application and Potential of Fecal Microbiota Transplantation. Annual Review of Medicine 2019; 70(1): 335 doi: 10.1146/annurev-med-111717-122956
42
Yandong Xiao, Marco Tulio Angulo, Songyang Lao, Scott T. Weiss, Yang-Yu Liu. An ecological framework to understand the efficacy of fecal microbiota transplantation. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-17180-x
43
Linxian Zhao, Tongbo Zhang, Kai Zhang. Pharmacological effects of ginseng and ginsenosides on intestinal inflammation and the immune system. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1353614
44
J. Sun, Y.L. Chen, Y.C. Ding, H. Zhong, M. Wu, Z.H. Liu, L.P. Ge. Deposition of resistant bacteria and resistome through FMT in germ‐free piglets. Letters in Applied Microbiology 2021; 73(2): 187 doi: 10.1111/lam.13490
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345